Literature DB >> 28683010

The incidence rates and survival of gallbladder cancer in the USA.

Veeravich Jaruvongvanich1,2, Ju Dong Yang3, Thoetchai Peeraphatdit3, Lewis R Roberts3.   

Abstract

Gallbladder cancer is a rare malignancy in most countries. The racial and sociodemographic factors associated with its incidence and survival are poorly defined. We aimed to investigate population-based gallbladder cancer incidence and survival trends on the basis of clinical characteristics and sociodemographic factors in the USA. Gallbladder cancer incidence and survival data from 2001 to 2012 were obtained from 18 registries of the Surveillance, Epidemiology, and End Results database. Incidence rates and Joinpoint trends were calculated by demographic subgroup. Survival trends were assessed using Cox proportional hazard models. A total of 7769 patients were identified. The overall gallbladder cancer incidence rates did not significantly change during the 2001-2012 period. Incidence rates were three times higher in Hispanics and 1.6 times higher in Blacks compared with Whites. Over the time period, incidence rates significantly increased among Blacks and decreased among Hispanics. Male sex [hazard ratio (HR): 1.10, 95% confidence interval (CI): 1.03-1.17], older age (HR: 1.73, 95% CI: 1.53-1.96), and single and divorced statuses (HR: 1.19, 95% CI: 1.09-1.30 and 1.12, 95% CI: 1.01-1.24) were independently associated with shorter overall survival, whereas higher education (HR: 0.89, 95% CI: 0.82-0.97) and higher income (HR: 0.89, 95% CI: 0.82-0.96) were associated with longer survival. Furthermore, overall survival has improved in all races/ethnicities except for Hispanics and Blacks. The overall incidence rates for gallbladder cancer were stable during 2001-2012. Hispanics have the highest incidence rates, but the incidence rates in Blacks are on the rise.

Entities:  

Mesh:

Year:  2019        PMID: 28683010     DOI: 10.1097/CEJ.0000000000000402

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  15 in total

1.  Establishment of a Gallbladder Cancer-Specific Survival Model to Predict Prognosis in Non-metastatic Gallbladder Cancer Patients After Surgical Resection.

Authors:  Woods Zhang; H J Hong; Yan-Ling Chen
Journal:  Dig Dis Sci       Date:  2018-05-08       Impact factor: 3.199

2.  Incidental gallbladder cancer diagnosis confers survival advantage irrespective of tumour stage and characteristics.

Authors:  Moath Alarabiyat; Syed Soulat Raza; John Isaac; Darius Mirza; Ravi Marudanayagam; Keith Roberts; Manuel Abradelo; David C Bartlett; Bobby V Dasari; Robert P Sutcliffe; Nikolaos A Chatzizacharias
Journal:  World J Gastroenterol       Date:  2022-05-14       Impact factor: 5.374

3.  Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.

Authors:  Alison L Van Dyke; Meredith S Shiels; Gieira S Jones; Ruth M Pfeiffer; Jessica L Petrick; Jennifer L Beebe-Dimmer; Jill Koshiol
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

4.  The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas.

Authors:  Esra Arslan; Tamer Aksoy; Nevra Dursun; Rıza Umar Gürsu; Mert Mahsuni Sevinç; Tevfik Fikret Çermik
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

Review 5.  Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico.

Authors:  Jacklyn M Nemunaitis; Ursa Brown-Glabeman; Heloisa Soares; Jessica Belmonte; Ben Liem; Itzhak Nir; Victor Phuoc; Rama R Gullapalli
Journal:  BMC Cancer       Date:  2018-06-18       Impact factor: 4.430

6.  Racial/ethnic disparities in gallbladder cancer receipt of treatments.

Authors:  Veeravich Jaruvongvanich; Buravej Assavapongpaiboon; Linda Wong
Journal:  J Gastrointest Oncol       Date:  2018-04

7.  Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013).

Authors:  Li Xu; Haidong Tan; Xiaolei Liu; Jia Huang; Liguo Liu; Shuang Si; Yongliang Sun; Wenying Zhou; Zhiying Yang
Journal:  Cancer Med       Date:  2020-03-31       Impact factor: 4.452

8.  Long-term outcomes and prognostic markers in gallbladder cancer.

Authors:  Xiwei Cui; Sha Zhu; Zhihang Tao; Xinghao Deng; Yexiao Wang; Yuanjing Gao; Yue Liao; Weijun Ma; Yiwen Zhang; Xuelei Ma
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Gallbladder cancer integrated bioinformatics analysis of protein profile data.

Authors:  Mohammad Reza Zali; Mona Zamanian Azodi; Zahra Razzaghi; Mohammad Hossain Heydari
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

10.  Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach.

Authors:  Vívian D'Afonseca; Ariel D Arencibia; Alex Echeverría-Vega; Leslie Cerpa; Juan P Cayún; Nelson M Varela; Marcela Salazar; Luis A Quiñones
Journal:  Cancer Inform       Date:  2020-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.